Clinical Trial Update: Evaluation of the Efficacy of Novel Biomarkers in Predicting Clopidogrel Resistance in Patients with Ischemic Stroke

View source ↗

Summary

Clinical trial evaluating novel biomarkers to predict clopidogrel resistance in patients with ischemic stroke; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Ischemic Stroke, TIA (Transient Ischemic Attack) | Status: NOT_YET_RECRUITING